This opportunity is no longer accepting applications.
grant PAR-24-035
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
This grant opportunity supports initial clinical trials focused on arthritis and diseases related to muscles, bones, and skin. It is aimed at early-stage research to explore innovative ideas in these areas, and conducting a clinical trial is a required part of the application.
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Funding Source
Agency: National Institutes of Health
Sub-agency: National Institute of Arthritis and Musculoskeletal and Skin Diseases
Program: SBIR
Dates
Application Window Closes: November 2, 2026
Opportunity Released: November 6, 2023
Open for Submission: November 6, 2023
Submission Deadline: November 2, 2026
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers